Stacie Dusetzina shares new research on the results of one of the largest efforts ever to improve care and control costs for cancer patients.
Cost of Care
Posted inCost of Care
Let’s Make a Deal…on Drug Prices
Democrats are on the brink of passing a historic set of drug price reforms. How will they impact patients, insurers and the drug industry?
Posted inInsurance
Has Medicaid Managed Care Delivered On Its Promise?
Letting private insurers offer Medicaid coverage was supposed to lower costs and improve care. Did it work?
Posted inHealth Law
What You Need to Know About the New Surprise Bill Rule
Katie Keith breaks down the newest rule outlining how new federal surprise bill legislation will be enforced.
Posted inCost of Care
Price Hikes Fuel Rising Employer Health Costs
Aditi Sen shares new data from the Health Care Cost Institute on health care spending, utilization and average price trends in the employer-sponsored insurance market.
Posted inCost of Care
What Happens When Price Transparency Meets Childbirth?
Jamie Daw looks at new research showing the uptake of a hospital price transparency tool for childbirth and its associations with cost of care.
Posted inCost of Care
What Happens When Urgent Care Comes to Town?
Bapu Jena digs into research looking at what happens to Medicare spending when urgent care centers enter a market.
Posted inCost of Care
The Aducanumab Aftermath: The Industry
How is the pharmaceutical industry reacting to the FDA’s surprising approval of a controversial Alzheimer’s drug?
Posted inCost of Care
The Aducanumab Aftermath: The Payer
A costly new Alzheimer’s drug could wreak financial havoc on insurers, seniors and taxpayers.
Posted inCost of Care
The Aducanumab Aftermath: The Doctor
One doctor grapples with questions about a controversial new Alzheimer’s drug’s safety and efficacy.